Drug profile · INN
arimoclomol citrate
MIPLYFFA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
arimoclomol citrate (MIPLYFFA) is an FDA-listed pharmaceutical active ingredient. Associated with ZEVRA THERAPEUTICS, INC.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN arimoclomol citrate
Brand MIPLYFFA
Route ORAL
Formulation CAPSULE
Originator ZEVRA THERAPEUTICS, INC.
Frequently asked questions
What is arimoclomol citrate?
arimoclomol citrate (MIPLYFFA) is an FDA-listed pharmaceutical active ingredient. Associated with ZEVRA THERAPEUTICS, INC.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for arimoclomol citrate?
MIPLYFFA is a marketed brand name for arimoclomol citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of arimoclomol citrate?
arimoclomol citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.